Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study
- PMID: 18614511
- PMCID: PMC2483869
- DOI: 10.1136/bmj.a180
Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study
Abstract
Objective: To determine the incidence of and mortality from bullous pemphigoid and pemphigus vulgaris in the United Kingdom.
Design: Retrospective historical cohort study.
Setting: Computerised medical records from the health improvement network, a large population based UK general practice database.
Participants: Patients with pemphigus vulgaris and bullous pemphigoid diagnostic codes and age, sex, and practice matched controls.
Main outcome measures: Incidence and mortality compared with the control population by calendar period, age group, sex, geographical region, and degree of social deprivation.
Results: 869 people with bullous pemphigoid and 138 people with pemphigus vulgaris were identified. The median age at presentation for bullous pemphigoid was 80 (range 23-102) years, and 534 (61%) patients were female. The median age at presentation for pemphigus vulgaris was 71 (21-102) years, and 91 (66%) patients were female. Incidences of bullous pemphigoid and pemphigus vulgaris were 4.3 (95% confidence interval 4.0 to 4.6) and 0.7 (0.6 to 0.8) per 100 000 person years. The incidence of bullous pemphigoid increased over time; the average yearly increase was 17% (incidence rate ratio=1.2, 95% confidence interval 1.1 to 1.2). An average yearly increase in incidence of pemphigus vulgaris of 11% (incidence rate ratio=1.1, 1.0 to 1.2) occurred. The risk of death for patients with bullous pemphigoid was twice as great as for controls (adjusted hazard ratio=2.3, 95% confidence interval 2.0 to 2.7). For pemphigus vulgaris, the risk of death was three times greater than for controls (adjusted hazard ratio=3.3, 2.2 to 5.2).
Conclusions: Incidences of bullous pemphigoid and pemphigus vulgaris are increasing. The reasons for the changes in incidence are not clearly understood but have implications for identifying causative factors. Both disorders are associated with a high risk of death. Previous estimates may have underestimated the risk of death associated with these diseases.
Conflict of interest statement
Competing interests: None declared.
Figures




Comment in
-
Incidence of bullous pemphigoid and pemphigus vulgaris.BMJ. 2008 Jul 9;337(7662):a209. doi: 10.1136/bmj.a209. BMJ. 2008. PMID: 18614512 Free PMC article.
-
Bullous pemphigoid: Is the incidence of pemphigoid really increasing?BMJ. 2008 Aug 6;337:a1138. doi: 10.1136/bmj.a1138. BMJ. 2008. PMID: 18684765 No abstract available.
Similar articles
-
Incidence of bullous pemphigoid and pemphigus vulgaris.BMJ. 2008 Jul 9;337(7662):a209. doi: 10.1136/bmj.a209. BMJ. 2008. PMID: 18614512 Free PMC article.
-
Validation study of bullous pemphigoid and pemphigus vulgaris recording in routinely collected electronic primary healthcare records in England.BMJ Open. 2020 Jul 14;10(7):e035934. doi: 10.1136/bmjopen-2019-035934. BMJ Open. 2020. PMID: 32665386 Free PMC article.
-
Risk of bullous pemphigoid and pemphigus in patients on chronic dialysis: A nationwide population-based cohort study.J Dermatol. 2023 Dec;50(12):1568-1575. doi: 10.1111/1346-8138.16948. Epub 2023 Sep 4. J Dermatol. 2023. PMID: 37665203
-
Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid.Arch Dermatol Res. 2015 May;307(4):291-8. doi: 10.1007/s00403-014-1531-1. Epub 2015 Jan 15. Arch Dermatol Res. 2015. PMID: 25589418 Review.
-
Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature.Dermatology. 2001;202(4):293-301. doi: 10.1159/000051661. Dermatology. 2001. PMID: 11455140 Review.
Cited by
-
Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management.Drugs Aging. 2016 Oct;33(10):711-723. doi: 10.1007/s40266-016-0402-1. Drugs Aging. 2016. PMID: 27738963 Review.
-
Prevalence of pemphigus and pemphigoid autoantibodies in the general population.Orphanet J Rare Dis. 2015 May 15;10:63. doi: 10.1186/s13023-015-0278-x. Orphanet J Rare Dis. 2015. PMID: 25971981 Free PMC article.
-
The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis.PLoS One. 2023 Nov 30;18(11):e0295135. doi: 10.1371/journal.pone.0295135. eCollection 2023. PLoS One. 2023. PMID: 38033098 Free PMC article.
-
Features and associated factors of bacterial skin infections in hospitalized patients with pemphigus: a single-center retrospective study.Ann Clin Microbiol Antimicrob. 2020 Oct 8;19(1):46. doi: 10.1186/s12941-020-00388-6. Ann Clin Microbiol Antimicrob. 2020. PMID: 33032608 Free PMC article.
-
Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis.PLoS One. 2022 Apr 15;17(4):e0264705. doi: 10.1371/journal.pone.0264705. eCollection 2022. PLoS One. 2022. PMID: 35427358 Free PMC article.
References
-
- Naldi L, Bertoni M, Cainelli T. Feasibility of a registry of pemphigus in Italy: two years experience. Int J Dermatol 1993;32:424-7. - PubMed
-
- Adam BA. Bullous diseases in Malaysia: epidemiology and natural history. Int J Dermatol 1992;31:42-5. - PubMed
-
- Garcia-Doval I, Mayo E, Nogueira Farina J, Cruces MJ. Bullous pemphigoid triggered by influenza vaccination? Ecological study in Galicia, Spain. Br J Dermatol 2006;155:820-3. - PubMed
-
- Jung M, Kippes W, Messer G, Zillikens D, Rzany B. Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence. J Am Acad Dermatol 1999;41:266-8. - PubMed
-
- Gudi VS, White MI, Cruickshank N, Herriot R, Edwards SL, Nimmo F, et al. Annual incidence and mortality of bullous pemphigoid in the Grampian region of north-east Scotland. Br J Dermatol 2005;153:424-7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical